WEDNESDAY, March 19, 2025 (HealthDay News) — For patients with chronic liver disease, statin use is associated with a reduced risk for hepatocellular carcinoma (HCC) and hepatic decompensation, according to a study published online March 17 in JAMA Internal Medicine. Jonggi Choi, M.D., Ph.D., from the University of Ulsan College of Medicine in Seoul, South […]
The post Statins May Reduce Risk for Hepatocellular Carcinoma in Chronic Liver Disease first appeared on Physician’s Weekly.
